Press "Enter" to skip to content

New patent for AKORN drug ZIOPTAN

0
Copyright © DrugPatentWatch. Originally published at New patent for AKORN drug ZIOPTAN

Annual Drug Patent Expirations for ZIOPTAN
Annual Drug Patent Expirations for ZIOPTAN

Zioptan is a drug marketed by Akorn and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.

ZIOPTAN drug price trends.

Drug patent litigation for ZIOPTAN.

This drug has sixty-eight patent family members in thirty-one countries.

The generic ingredient in ZIOPTAN is tafluprost. One supplier is listed for this compound. Additional details are available on the tafluprost profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for AKORN drug ZIOPTAN
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    Do NOT follow this link or you will be banned from the site!